Topic Menu
► Topic MenuTopic Editors
2. Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Vila Real, Portugal
2. Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
Prostate Cancer: Symptoms, Diagnosis & Treatment - 2nd Volume
Topic Information
Dear Colleagues,
This Topic is a continuation of the previous successful Topic "Prostate Cancer: Symptoms, Diagnosis & Treatment" (https://www.mdpi.com/topics/prostate_Cancer).
The prostate is the largest accessory gland of the male reproductive tract. Together with seminal vesicles and bulbourethral glands, the prostate is responsible for the production of an alkaline fluid that forms part of the seminal fluid. The prostates of men over 40 years of age are commonly affected by several pathologies, such as benign prostate hyperplasia and cancer. Prostate cancer is one of the most common cancers among the male population worldwide. According to the World Health Organization (WHO), in the year 2020, prostate cancer affected approximately 1.41 million men worldwide. Despite significant treatment improvements having been achieved with the advent of targeted and immune-checkpoint-inhibitor-based therapies, cancer remains one of the primary causes of death worldwide. Therefore, this Topic will consider articles on all types of research on prostate cancer, including in vitro and in vivo approaches. Submission of research on the impact of the tumor macroenvironment (microbiota, diet, physical exercise) on tumor biology, as well as review studies, will also be welcome. We sincerely invite scientists to publish their excellent work in one of the following five journals: Cancers, Diagnostics, Current Oncology, BioMed, or Uro.
Dr. Ana Faustino
Dr. Paula A. Oliveira
Prof. Dr. Lúcio Lara Santos
Topic Editors
Keywords
- cancer biology
- in vitro
- in vivo
- resistance
- treatment
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
BioMed
|
- | - | 2021 | 20.3 Days | CHF 1000 |
Cancers
|
4.5 | 8.0 | 2009 | 16.3 Days | CHF 2900 |
Current Oncology
|
2.8 | 3.3 | 1994 | 17.6 Days | CHF 2200 |
Diagnostics
|
3.0 | 4.7 | 2011 | 20.5 Days | CHF 2600 |
Uro
|
- | - | 2021 | 21.9 Days | CHF 1000 |
Preprints.org is a multidiscipline platform providing preprint service that is dedicated to sharing your research from the start and empowering your research journey.
MDPI Topics is cooperating with Preprints.org and has built a direct connection between MDPI journals and Preprints.org. Authors are encouraged to enjoy the benefits by posting a preprint at Preprints.org prior to publication:
- Immediately share your ideas ahead of publication and establish your research priority;
- Protect your idea from being stolen with this time-stamped preprint article;
- Enhance the exposure and impact of your research;
- Receive feedback from your peers in advance;
- Have it indexed in Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.